USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities
04-Sep-2018
North America
Market Research
ME1D-01-00-00-00
HC03076-NA-MR_22287
The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally enabled by the entry of non-traditional tech companies such as Apple, Facebook, and Google—pushing pharmaceutical companies to go beyond-the-pill. However, in the midst of this chaos, there are pioneering companies offering solutions that apply cutting-edge digital technologies such as AI, Big Data and analytics, cloud, mobile, blockchain, and Internet of Things (IoT) to build digital convergence across the pharmaceutical value chain, covering R&D, manufacturing and operations, marketing, and patient connect. This Companies to Action (C2A) analysis puts the spotlight on such game-changing, tech-enabled participants and how they are altering the status-quo by highlighting novel monetization models and strategic investment opportunities.
Research Scope
The key objective of this study is to highlight current market dynamics, key market participants, customer segments, and evolving business opportunities. The study aims to identify pioneering companies that are capable of shaping the future through best practices implementation, visionary leadership, and innovation in business models. The company profiles offer insights around key solution offerings, target customer segments, service differentiators, and future growth strategies.
Further, the global study provides an analysis of companies segregated by market segments such as: smart R&D, flexible manufacturing, connected patients, and digital pharmacy. The analysis covers technologies such as Artificial intelligence (AI), Big Data and analytics, crowdsourcing, mobile, Industrial IoT (IIoT), IoT, cloud, blockchain, eCommerce, and so on.
The participants mentioned in the study are iSolve, Zephyr Health, PillPack, Proteus Digital Health, BenevolentAI, Elemental Machines, Exscientia, Science 37, Transparency Life Sciences, and uMotif. It also lists the wider universe of companies that were assessed for this analysis. These companies were chosen based factors such as innovative technology development and application, hitting the right focus areas, proven success and industry recognition, and enhanced client collaborations.
Key Issues Addressed
- How are companies creating extraordinary value for pharmaceutical stakeholders?
- Which are some unique companies that are introducing new and innovative solutions in the market?
- How do these companies intend to transform the healthcare industry paradigms in the future? What is the impact of the external industry environment on this market?
- What is their action plan and potential for growth? What are the current growth opportunities in digital transformation?
- What are some key success factors in the pharmaceutical market?
- Which are the companies with whom partnerships can be forged?
Key Findings
Methodology
Scope and Segmentation
Key Questions this Study will Answer
Pillars of Digital Transformation and Growth Opportunity in Pharmaceuticals
Tackling Challenges in the Pharmaceuticals Industry
Major Challenges Limiting Digital Transformation
Companies-to-Action Value Creators
Threats and Opportunities
Strategic Imperatives for Digital Transformation in Pharmaceuticals
Definition and Solution Segmentation
Impact of Key Market Influencers
Pillars of Digital Transformation and Vendor Strategies
C2A Targets Aligned With Pillars of Digital Transformation
Value Chain Analysis
Benchmarking of Top Companies-to-Action
BenevolentAI
BenevolentAI (continued)
Exscientia
Exscientia (continued)
Science 37
Science 37 (continued)
Transparency Life Science
Transparency Life Sciences (continued)
Elemental Machines
Elemental Machines (continued)
iSolve
iSolve (continued)
PillPack
PillPack (continued)
Zephyr Health
Zephyr Health (continued)
Proteus Digital Health
Proteus Digital Health (continued)
uMotif
uMotif (continued)
Building Life Science Digital Capabilities by Innovation Tracking
Conclusion—Key Takeaways From the Companies-to-Action Analysis
Legal Disclaimer
List of Vendors Assessed
List of Vendors Assessed (continued)
List of Vendors Assessed (continued)
List of Vendors Assessed (continued)
List of Vendors Assessed (continued)
List of Vendors Assessed (continued)
List of Vendors Assessed (continued)
List of Vendors Assessed (continued)
List of Exhibits
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Scope
The key objective of this study is to highlight current market dynamics, key market participants, customer segments, and evolving business opportunities. The study aims to identify pioneering companies that are capable of shaping the future through best practices implementation, visionary leadership, and innovation in business models. The company profiles offer insights around key solution offerings, target customer segments, service differentiators, and future growth strategies.
Further, the global study provides an analysis of companies segregated by market segments such as: smart R&D, flexible manufacturing, connected patients, and digital pharmacy. The analysis covers technologies such as Artificial intelligence (AI), Big Data and analytics, crowdsourcing, mobile, Industrial IoT (IIoT), IoT, cloud, blockchain, eCommerce,
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Neelotpal Goswami |
| Industries | Healthcare |
| WIP Number | ME1D-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9562-B1,9564-B1,9568-B1,9571-B1,9573-B1,9575-B1,9600-B1,9611-B1,9612-B1,9627-B1,99BC-B1,99C1-B1,99C6-B1,9A42-B1,9A43-B1,9A44-B1,9A4E-B1 |
Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018
$3,000.00
Special Price $2,250.00 save 25 %